TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32231850

Group type: EXPERIMENTAL
Intervention: Induction of labor with oxytocin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Spontaneous onset of labor
Number of subjects: 50
Study: 35668643

Group type: EXPERIMENTAL
Intervention: Expert instruction (EXP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Video instruction (VID)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (EXP and VID)
Number of subjects: 60
Study: 35318277

Group type: EXPERIMENTAL
Intervention: Olaparib beyond progression
Number of subjects: 200

Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 200
Study: 32840311

Group type: EXPERIMENTAL
Intervention: Lower SHBG
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Higher testosterone
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Higher estrone, estradiol, and testosterone
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Higher estradiol
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: DHEAS
Number of subjects: 573

Group type: EXPERIMENTAL
Intervention: Androstenedione
Number of subjects: 573
Study: 34759989

Group type: EXPERIMENTAL
Intervention: Apple syrup (Malus domestica), administered three times a day along with antiemetic treatment and chemotherapy
Number of subjects: 34
Study: 32086442

Group type: EXPERIMENTAL
Intervention: 10,000 voluntary contractions over 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care alone (Control Group)
Number of subjects: 120
Study: 35044877

Group type: EXPERIMENTAL
Intervention: 1sIPV+2bOPV
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: 2sIPV+1bOPV
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: 2sIPV+1tOPV
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: 1cIPV+2bOPV
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: 2cIPV+1bOPV
Number of subjects: 968

Group type: EXPERIMENTAL
Intervention: 2cIPV+1tOPV
Number of subjects: 968

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 968
Study: 33144461

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT) using the PICO™ device
Number of subjects: 20
Study: 34252252

Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment (T group)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Anti-inflammatory mouthwash (M group)
Number of subjects: 38
Study: 33340751

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 1706

Group type: COMPARATOR
Intervention: Laparotomy (Control)
Number of subjects: 1706
Study: 32355959

Group type: EXPERIMENTAL
Intervention: Exercise combined with paired corticospinal‐motor neuronal stimulation (PCMS)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: PCMS without exercise
Number of subjects: 25

Group type: COMPARATOR
Intervention: Exercise combined with sham‐PCMS
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise with PCMS
Number of subjects: 25

Group type: COMPARATOR
Intervention: Exercise with sham‐PCMS
Number of subjects: 25
Study: 34264351

Group type: EXPERIMENTAL
Intervention: Deep learning-based algorithm
Number of subjects: 3073
Study: 32205226

Group type: EXPERIMENTAL
Intervention: Lusutrombopag (3 mg) daily for 7 days before the invasive procedure
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Lusutrombopag
Number of subjects: 270
Study: 33685873

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 104)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (n = 102)
Number of subjects: 206
Study: 32016644

Group type: EXPERIMENTAL
Intervention: 24 h severe energy restriction (ER)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Standardised breakfast followed by ad libitum lunch and dinner
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ad libitum energy intake on day 2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Postprandial responses for CTX, P1NP, and PTH
Number of subjects: 16
Study: 34636852

Group type: EXPERIMENTAL
Intervention: Younger patients (yoCRC cohort)
Number of subjects: 2326

Group type: COMPARATOR
Intervention: Older patients (50 years and older)
Number of subjects: 2326

Group type: EXPERIMENTAL
Intervention: Patients younger than age 35 years
Number of subjects: 2326
Study: 34581270

Group type: EXPERIMENTAL
Intervention: Tamoxifen 300 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care (amphotericin combined with fluconazole)
Number of subjects: 50
Study: 33432367

Group type: EXPERIMENTAL
Intervention: Irradiated area cohort
Number of subjects: 100

Group type: COMPARATOR
Intervention: De novo cohort
Number of subjects: 100
Study: 32686744

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (cholecalciferol at 2000 IU) for 2 months
Number of subjects: 90
Study: 35915923

Group type: EXPERIMENTAL
Intervention: Angiotensin-2
Number of subjects: 60

Group type: COMPARATOR
Intervention: Noradrenaline
Number of subjects: 60
Study: 34647315

Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between Nonoperative and Surgical groups
Number of subjects: 30
Study: 32314828

Group type: EXPERIMENTAL
Intervention: sirolimus-based immunosuppression + CNIs (group B1; n = 44)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: sirolimus-based immunosuppression + CNIs (group B2; n = 34)
Number of subjects: 166

Group type: COMPARATOR
Intervention: CNI-based immunosuppression (group A; n = 88)
Number of subjects: 166
Study: 34334142

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention by a pharmacist trained in motivational interviewing
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 316
Study: 33049287

Group type: EXPERIMENTAL
Intervention: Pragmatic care trials with 1:1 randomized allocation
Number of subjects: 1212

Group type: EXPERIMENTAL
Intervention: Pragmatic care trials
Number of subjects: 1212
Study: 35654683

Group type: EXPERIMENTAL
Intervention: 0.01% atropine with orthokeratology (AOK)
Number of subjects: 96

Group type: COMPARATOR
Intervention: orthokeratology (OK)
Number of subjects: 96
Study: 33496775

Group type: EXPERIMENTAL
Intervention: In-clinic group intervention (n=468)
Number of subjects: 1407

Group type: EXPERIMENTAL
Intervention: Telephone group intervention (n=466)
Number of subjects: 1407

Group type: COMPARATOR
Intervention: In-clinic individual intervention (n=473)
Number of subjects: 1407
Study: 35878584

Group type: EXPERIMENTAL
Intervention: Antidepressants treatment (specifics not provided)
Number of subjects: 25
Study: 34052918

Group type: EXPERIMENTAL
Intervention: Synchronous contralateral axillary metastasis (CAM) diagnosis
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Diagnostic evaluations for CAM
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Stage IV isolated CAM
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Stage IV non-CAM
Number of subjects: 588

Group type: EXPERIMENTAL
Intervention: Stage IV CAM plus other distant metastasis
Number of subjects: 588
Study: 33190009

Group type: EXPERIMENTAL
Intervention: Electromoxibustion (EM) - 12 sessions over 4 weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Knee health education - 2 sessions
Number of subjects: 38
Study: 35437059

Group type: EXPERIMENTAL
Intervention: EDS-FLU 186 µg
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: EDS-FLU 372 µg
Number of subjects: 482

Group type: COMPARATOR
Intervention: EDS-placebo
Number of subjects: 482
Study: 33858234

Group type: EXPERIMENTAL
Intervention: 15 hours of intervention per week
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: 25 hours of intervention per week
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Lower intensity intervention
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Higher intensity intervention
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Home-based comprehensive intervention program
Number of subjects: 87
Study: 32632450

Group type: EXPERIMENTAL
Intervention: EOC: 44.1 mg/kg CS
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control: without MON or EOC added to the calf starter (CS)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MON: 50.8 mg/kg CS
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: MON + EOC
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: EOC or MON + EOC
Number of subjects: 80
Study: 35501519

Group type: EXPERIMENTAL
Intervention: 755-nm picosecond alexandrite laser with topical tranexamic acid (TTA) combination therapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Laser monotherapy
Number of subjects: 37
Study: 33902485

Group type: EXPERIMENTAL
Intervention: Machine learning prediction model (random forest, XGBoost, logistic regression)
Number of subjects: 5508
Study: 34865009

Group type: EXPERIMENTAL
Intervention: Cognition (COG)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Gross Motor Abilities (GMA)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Aerobic Training (AET)
Number of subjects: 78
Study: 32713772

Group type: EXPERIMENTAL
Intervention: Humanoid companion robot (Kabochan)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual standardized care
Number of subjects: 103
Study: 33991254

Group type: EXPERIMENTAL
Intervention: Hydrolyzed meat protein (HMP)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Steak
Number of subjects: 12

Group type: COMPARATOR
Intervention: Minced meat
Number of subjects: 12
Study: 33745386

Group type: EXPERIMENTAL
Intervention: Nurse coached walking intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 35000945

Group type: EXPERIMENTAL
Intervention: Pulpotec
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Pulpotec + PAD
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Biodentine + PAD
Number of subjects: 80
Study: 35402989

Group type: EXPERIMENTAL
Intervention: Propofol + Granisetron
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol + Metoclopramide
Number of subjects: 60
Study: 33830415

Group type: EXPERIMENTAL
Intervention: Contrastive Lexical Approach (CLA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ordinary traditional instruction
Number of subjects: 40
Study: 33021563

Group type: EXPERIMENTAL
Intervention: Ropivacaine (local anesthetic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study: 32584651

Group type: EXPERIMENTAL
Intervention: Why-quit messages with distant temporal frames
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Why-quit messages with proximal temporal frames
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: How-to-quit messages
Number of subjects: 0
Study: 34117867

Group type: EXPERIMENTAL
Intervention: Adiponectin levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) analyses
Number of subjects: 0
Study: 32017863

Group type: EXPERIMENTAL
Intervention: Incubation temperatures of 14°C to 30°C
Number of subjects: 0
Study: 33480087

Group type: EXPERIMENTAL
Intervention: MYC-translocated tumors
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: BCL6 translocated tumors
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Cluster B tumors
Number of subjects: 126
Study: 33317479

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35852487

Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Psychotherapy for Cancer Caregivers (MCP‐C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 60
Study: 33559413

Group type: EXPERIMENTAL
Intervention: Olaparib maintenance with pembrolizumab and bevacizumab
Number of subjects: 44
Study: 32109293

Group type: EXPERIMENTAL
Intervention: Tenofovir-diphosphate detection
Number of subjects: 201
Study: 33482902

Group type: EXPERIMENTAL
Intervention: Human amniotic fluid (hAF)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Higher dose of intravenous hAF (in the last 6 patients)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No intervention (control group not explicitly mentioned)
Number of subjects: 10
Study: 32440816

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids at a daily dose of 1000 mg for 30 days
Number of subjects: 452

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 452
Study: 34006508

Group type: EXPERIMENTAL
Intervention: Subretinal AAV8.CNGA3 gene therapy
Number of subjects: 9
Study: 35002315

Group type: EXPERIMENTAL
Intervention: Heparinoid moisturizer applied during 3 weeks of hypofractionated whole-breast irradiation with or without boost until 4 weeks after completion of irradiation.
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 72
Study: 33040631

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum IS-10506 (2 × 10^10 CFU/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (skim milk-Avicel)
Number of subjects: 30
Study: 34030027

Group type: EXPERIMENTAL
Intervention: Buprenorphine (administered two hours before assessment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (trough group)
Number of subjects: 60
Study: 32760865

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 377
Study: 33880692

Group type: EXPERIMENTAL
Intervention: INCLUSIVE whole-school intervention
Number of subjects: 8179

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 8179
Study: 34477246

Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 32170867

Group type: EXPERIMENTAL
Intervention: Liposomal vincristine with hyper-CMAD
Number of subjects: 31
Study: 35610642

Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intra-articular hyaluronan (HA) injections
Number of subjects: 0
Study: 33033846

Group type: EXPERIMENTAL
Intervention: Boss‐Holtzach‐Matter technique
Number of subjects: 58
Study: 34404045

Group type: EXPERIMENTAL
Intervention: Herbal oil cream
Number of subjects: 135

Group type: COMPARATOR
Intervention: Calcipotriol (0.05%)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 135
Study: 32361843

Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Percutaneous Vertebroplasty (PVP)
Number of subjects: 139
Study: 36075246

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly with background statins with or without ezetimibe for 80 weeks
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly
Number of subjects: 150
Study: 34810387

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy containing natural lycopene with green tea extract
Number of subjects: 48

Group type: COMPARATOR
Intervention: Full mouth scaling and root planing (Control)
Number of subjects: 48
Study: 32865079

Group type: EXPERIMENTAL
Intervention: Computer-Delivered Brief Intervention (CDBI) with various components (animated narrator, spoken voice, empathic reflections, motivational interviewing)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Computer-Delivered Brief Intervention (CDBI) without specific components
Number of subjects: 352
Study: 36099282

Group type: EXPERIMENTAL
Intervention: Personalized biological feedback related to physical activity behaviors
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard educational material
Number of subjects: 50
Study: 34202314

Group type: EXPERIMENTAL
Intervention: Duloxetine 30 mg once a day
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 34495340

Group type: EXPERIMENTAL
Intervention: Extended-Release Buprenorphine (XRB)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Daily Sublingual Buprenorphine-Naloxone (SLB)
Number of subjects: 52
Study: 33283485

Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 45 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 90 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 120 mg (single dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35123014

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with different illumination times
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no illumination)
Number of subjects: 70
Study: 32588418

Group type: EXPERIMENTAL
Intervention: Monofilament synthetic absorbable sutures
Number of subjects: 95

Group type: COMPARATOR
Intervention: Multifilament synthetic absorbable sutures
Number of subjects: 95
Study: 35559241

Group type: EXPERIMENTAL
Intervention: Probiotic supplements
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 32679755

Group type: EXPERIMENTAL
Intervention: 3D moving platform exercise (3DEG)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 29
Study: 35426781

Group type: EXPERIMENTAL
Intervention: i-gel® (supraglottic airway)
Number of subjects: 9296

Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 9296
Study: 34258270

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 121
Study: 35895098

Group type: EXPERIMENTAL
Intervention: Gefapixant 45 mg twice daily
Number of subjects: 1360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1360
Study: 35124914

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 100
Study: 34253679

Group type: EXPERIMENTAL
Intervention: LCA-derived subphenotypes (hyperinflammatory subphenotype)
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: LCA-derived subphenotypes
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Measurement of novel biomarkers
Number of subjects: 959
Study: 34847699

Group type: EXPERIMENTAL
Intervention: Hip exercises
Number of subjects: 218

Group type: COMPARATOR
Intervention: Foot orthoses
Number of subjects: 218
Study: 33301646

Group type: EXPERIMENTAL
Intervention: POLST specifying 'CPR'
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Document
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: POLST/ do not resuscitate-comfort measures only (DNR-CMO)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: LW or POLST specifying DNR combined with medical support
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Documents (LW or POLST)
Number of subjects: 57

Group type: COMPARATOR
Intervention: No Document and POLST/CPR
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: POLST DNR/Limited Treatment
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Prior training in LWs and POLST
Number of subjects: 57
Study: 35733519

Group type: EXPERIMENTAL
Intervention: Training plus spirulina (T+S)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Training plus placebo (T+P)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Spirulina (S)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 60
Study: 33775313

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination treatment of BEV and Stupp protocol
Number of subjects: 0
Study: 33049412

Group type: EXPERIMENTAL
Intervention: 2 mA tDCS stimulation for 20 minutes during a two-week cognitive training intervention
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 2 mA tDCS stimulation
Number of subjects: 14
Study: 36243317

Group type: EXPERIMENTAL
Intervention: Development of a taxonomy for acute needle pain based on a 5-dimensional structure.
Number of subjects: 0
Study: 33137868

Group type: EXPERIMENTAL
Intervention: Motor imagery-based training program
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (watching videos about the history of the Olympic Games)
Number of subjects: 27
Study: 34991426

Group type: EXPERIMENTAL
Intervention: Serum Ca-125 levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abdominal lavage fluid Ca-125 levels
Number of subjects: 0
Study: 33678218

Group type: EXPERIMENTAL
Intervention: Nutritional warnings (black octagonal signs with the word 'Excess')
Number of subjects: 447

Group type: COMPARATOR
Intervention: Control (no nutritional warnings)
Number of subjects: 447
Study: 35086570

Group type: EXPERIMENTAL
Intervention: Oat flour with pulses
Number of subjects: 42

Group type: COMPARATOR
Intervention: Rice flour with pulses
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Oat flour meal
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Hydrogen production
Number of subjects: 42
Study: 33866072

Group type: EXPERIMENTAL
Intervention: 70% THC cannabis concentrate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 90% THC cannabis concentrate
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ad libitum cannabis concentrate use
Number of subjects: 65
Study: 35586118

Group type: EXPERIMENTAL
Intervention: PR maintenance via social media supervision at home (Group A)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: PR maintenance at hospital (Group B)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Usual care (Group C)
Number of subjects: 140
Study: 33798499

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AZD1222) vaccine
Number of subjects: 8534

Group type: COMPARATOR
Intervention: Meningococcal conjugate control (MenACWY) vaccine
Number of subjects: 8534
Study: 33164953

Group type: EXPERIMENTAL
Intervention: Neurorestoration protocol (n=32) for 7 days
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional physiotherapy (n=32) for 7 days
Number of subjects: 64
Study: 33794672

Group type: EXPERIMENTAL
Intervention: RFQY-5 (shortened version of the Reflective Function Questionnaire for Youth)
Number of subjects: 1204

Group type: EXPERIMENTAL
Intervention: RFQY-5
Number of subjects: 1204

Group type: COMPARATOR
Intervention: Original 23-item RFQY
Number of subjects: 1204
Study: 32869124

Group type: EXPERIMENTAL
Intervention: 1.0 g TXA
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: 2.0 g TXA
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: 3.0 g TXA
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: 0.5 g TXA
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control
Number of subjects: 325